ID: ALA3397485

Max Phase: Preclinical

Molecular Formula: C34H51N3Na2O20S3

Molecular Weight: 920.00

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)N[C@H]1[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)CNc2cccc(NC(=O)CCCCC3CCSS3)c2)O[C@H](COS(=O)(=O)[O-])[C@H](O)[C@@H]1O[C@@H]1O[C@H](C(=O)[O-])[C@@H](O)[C@H](O)[C@H]1O.[Na+].[Na+]

Standard InChI:  InChI=1S/C34H53N3O20S3.2Na/c1-15(38)36-23-30(56-34-29(47)27(45)28(46)31(57-34)32(48)49)26(44)21(14-54-60(50,51)52)55-33(23)53-13-20(40)25(43)24(42)19(39)12-35-16-5-4-6-17(11-16)37-22(41)8-3-2-7-18-9-10-58-59-18;;/h4-6,11,18-21,23-31,33-35,39-40,42-47H,2-3,7-10,12-14H2,1H3,(H,36,38)(H,37,41)(H,48,49)(H,50,51,52);;/q;2*+1/p-2/t18?,19-,20+,21+,23+,24+,25+,26-,27-,28-,29+,30+,31-,33-,34+;;/m0../s1

Standard InChI Key:  YHDBYHHCXWZETJ-HKAVKJCZSA-L

Associated Targets(Human)

FGF2 Tchem Basic fibroblast growth factor (185 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 920.00Molecular Weight (Monoisotopic): 919.2385AlogP: -3.10#Rotatable Bonds: 22
Polar Surface Area: 369.89Molecular Species: ACIDHBA: 21HBD: 13
#RO5 Violations: 3HBA (Lipinski): 23HBD (Lipinski): 13#RO5 Violations (Lipinski): 3
CX Acidic pKa: -2.14CX Basic pKa: 3.70CX LogP: -4.18CX LogD: -9.47
Aromatic Rings: 1Heavy Atoms: 60QED Weighted: 0.03Np Likeness Score: 0.91

References

1. Wakao M, Obata R, Miyachi K, Kaitsubata Y, Kondo T, Sakami C, Suda Y..  (2015)  Synthesis of a chondroitin sulfate disaccharide library and a GAG-binding protein interaction analysis.,  25  (7): [PMID:25765912] [10.1016/j.bmcl.2015.02.054]

Source